Sage Journals: Discover world-class research

Abstract

Get full access to this article

View all access options for this article.

References

Advisory Council on the Misuse of Drugs. “NBOMe” compounds: a review of the evidence of use and harm. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/261786/NBOMe_compounds_report.pdf. Published November 28, 2013. Accessed June 23, 2015.

Rose

, Poklis

A case of 25I-NBOMe (25-I) intoxication: a new potent 5-HT2A agonist designer drug. Clin Toxicol (Phila). 2013;51:174–177.

Drug Enforcement Administration. Department of Justice. Schedules of controlled substances: temporary placement of three synthetic phenethylamines into Schedule I. Final order. Fed Regist. 2013;78:68716–68719.

Hill

, Doris

, Gurung

, . Severe clinical tox-icity associated with analytically confirmed recreational use of 25I–NBOMe: case series. Clin Toxicol (Phila). 2013;51:487–492.

Walterscheid

, Phillips

G T

, Lopez

, . Pathological findings in 2 cases of fatal 25I-NBOMe toxicity. Am J Forensic Med Pathol. 2014;35:20–25.

Halberstadt

, Geyer

MA.

Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response. Neuropharmacology. 2014;77:200–207.

Near-Lethal Violent Suicide Attempt in a 15-Year-Old Adolescent with No Prior Psychiatric History following Ingestion of ‘N-Bomb’ Drug

Abstract

Get full access to this article

References